How to evaluate Stock solution stability according to EMA guideline [Bioanalytics]

posted by chandru – India, 2018-05-27 21:26 (876 d 07:33 ago) – Posting: # 18819
Views: 2,177

Hi Ohlbe,

Is it ok to evaluate working solution stability according to FDA guidance May 2018 at LQC and HQC level.

As they have spoken about stock solution stability which has to be done at LQC and HQC level. Does it apply for working solution stability?


Complete thread:

 Admin contact
21,162 posts in 4,410 threads, 1,476 registered users;
online 2 (0 registered, 2 guests [including 2 identified bots]).
Forum time: Tuesday 04:59 CEST (Europe/Vienna)

In theory, there is no difference between theory and practice.
But, in practice, there is.    Jan L.A. van de Snepscheut

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz